Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$977M |
| 2 |
Verizon
VZ
|
+$429M |
| 3 |
AstraZeneca
AZN
|
+$420M |
| 4 |
Texas Instruments
TXN
|
+$420M |
| 5 |
General Dynamics
GD
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$863M |
| 2 |
Electronic Arts
EA
|
+$765M |
| 3 |
Eaton
ETN
|
+$556M |
| 4 |
Meta Platforms (Facebook)
META
|
+$535M |
| 5 |
Applied Materials
AMAT
|
+$534M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Financials | 11.45% |
| 3 | Healthcare | 7.98% |
| 4 | Industrials | 7.85% |
| 5 | Consumer Discretionary | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Medifast
MED
$110M
| $139K | ﹤0.01% |
13,019
-44,817
| -77% | -$536K |
|
3927
Emergent Biosolutions
EBS
$375M
| $139K | ﹤0.01% |
11,235
-20,038
| -64% | -$215K |
|
3928
MannKind Corp
MNKD
$1.27B
| $136K | ﹤0.01% |
23,962
+6,907
| +40% | +$38K |
|
3929
Caribou Biosciences
CRBU
$150M
| $135K | ﹤0.01% |
85,104
-250
| -0.3% | -$525 |
|
3930
Star Group
SGU
$412M
| $134K | ﹤0.01% |
11,352
-24
| -0.2% | -$284 |
|
3931
B&G Foods
BGS
$293M
| $134K | ﹤0.01% |
30,015
-18,512
| -38% | -$82.7K |
|
3932
Cornerstone Strategic Value Fund
CLM
$2.18B
| $133K | ﹤0.01% |
15,916
-14
| -0.1% | -$116 |
|
|
BTA
3933
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $131K | ﹤0.01% |
14,145
+4,125
| +41% | +$39.1K |
|
|
CIK
3934
Credit Suisse Asset Management Income Fund
CIK
$134M
| $131K | ﹤0.01% |
46,325
-24,664
| -35% | -$70.3K |
|
3935
Lipocine
LPCN
$17.4M
| $129K | ﹤0.01% |
+16,104
| New | +$54.2K |
|
3936
DocGo
DCGO
$65.9M
| $129K | ﹤0.01% |
+147,170
| New | +$157K |
|
|
MFA
3937
MFA Financial
MFA
$935M
| $127K | ﹤0.01% |
13,631
+1,936
| +17% | +$18K |
|
3938
Suzano
SUZ
$10.4B
| $127K | ﹤0.01% |
+13,297
| New | +$121K |
|
3939
Invesco Pennsylvania Value Municipal Income Trust
VPV
$196M
| $124K | ﹤0.01% |
11,822
| – | – |
|
3940
Replimune Group
REPL
$455M
| $122K | ﹤0.01% |
12,585
+196
| +2% | +$1.67K |
|
3941
QuantumScape Corp
QS
$3.22B
| $122K | ﹤0.01% |
11,736
-9,033
| -43% | -$125K |
|
|
MMT
3942
Aberdeen Multi-Market Income Fund
MMT
$237M
| $122K | ﹤0.01% |
26,174
-2,698
| -9% | -$12.7K |
|
3943
Opko Health
OPK
$993M
| $121K | ﹤0.01% |
96,242
+1,001
| +1% | +$1.39K |
|
|
ACH
3944
Accendra Health
ACH
$256M
| $121K | ﹤0.01% |
+43,138
| New | +$154K |
|
|
MHN
3945
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $120K | ﹤0.01% |
11,728
| – | – |
|
|
CRF
3946
Cornerstone Total Return Fund
CRF
$1.14B
| $119K | ﹤0.01% |
14,854
| – | – |
|
3947
Veritone
VERI
$97.6M
| $115K | ﹤0.01% |
24,680
| – | – |
|
3948
TriplePoint Venture Growth BDC
TPVG
$185M
| $113K | ﹤0.01% |
17,345
-8,242
| -32% | -$49.4K |
|
|
EVF
3949
Eaton Vance Senior Income Trust
EVF
$90.1M
| $113K | ﹤0.01% |
21,487
-22,184
| -51% | -$119K |
|
3950
Superior Group of Companies
SGC
$192M
| $113K | ﹤0.01% |
11,636
-190
| -2% | -$1.86K |
|
Similar funds
Ameriprise's Q4 2025 Portfolio in Review
As of Q4 2025, Ameriprise held 4,249 positions worth $443B, up 1.6% from $435B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2025 filing shows 211 new, 1,747 increased, 1,995 reduced and 178 closed positions. Its largest new stake was NexGen Energy: 8,483,607 shares worth $78M. The largest sale was Alphabet (Google) Class A, an estimated $863M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2025 buy was NexGen Energy: 8,483,607 shares worth $78M.
- Ameriprise added most to Salesforce in Q4 2025, an estimated $977M increase.
- Ameriprise's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $863M.
- Ameriprise fully exited Merus in Q4 2025, selling an estimated $84.6M.
- Ameriprise's ten largest holdings make up 21% of its $443B portfolio in Q4 2025.
- Ameriprise opened 211 new positions and closed 178 in Q4 2025.
- Ameriprise's portfolio value rose 1.6% quarter-over-quarter to $443B.
Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.